ACIUのニュース
Can you now get a good deal on AC Immune SA’s shares? 2023/02/09 15:24:00 US Post News
A share of AC Immune SA (NASDAQ:ACIU) closed at $2.38 per share on Wednesday, down from $2.42 day before. While AC Immune SA has underperformed by -1.65%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ACIU fell by -49.15%, with highs and lows ranging from $4.84 […]
AC Immune SA: AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 2023/02/07 12:10:00 Finanz Nachrichten
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 The Michael J. Fox Foundation grant supports the development of AC Immune''s first-in-class TDP-43 PET trac…
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 2023/02/07 12:00:00 GlobeNewswire
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43
AC Immune SA: AC Immune to Present at the SVB Securities Global Biopharma Conference 2023/02/02 13:22:00 Finanz Nachrichten
AC Immune to Present at the SVB Securities Global Biopharma Conference Lausanne, Switzerland, February 2, 2023 - AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering p…
AC Immune to Present at the SVB Securities Global Biopharma 2023/02/02 13:15:00 businessfortnight.com
AC Immune to Present at the SVB Securities Global Biopharma Conference Lausanne, Switzerland, February 2, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for […] The post AC Immune to Present at the SVB Securities Global Biopharma appeared first on Businessfortnight .
How should investors view AC Immune SA (ACIU)? 2023/01/06 14:54:00 US Post News
AC Immune SA (NASDAQ:ACIU) marked $2.13 per share on Thursday, down from a previous closing price of $2.18. While AC Immune SA has underperformed by -2.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ACIU fell by -57.65%, with highs and lows ranging from $5.12 to […]
A Full Position In AC Immune To My Tax Loss Selling Basket (ACIU) 2022/12/27 18:02:46 Seeking Alpha
AC Immune recently fell due to what looks like indiscriminate tax loss selling. It now trades at near cash on hand. Read why I have a full position in ACIU.
Boom Or Bust: What Does The Future Hold For AC Immune SA (NASDAQ: ACIU) Stock? 2022/12/22 16:00:00 Marketing Sentinel
AC Immune SA (NASDAQ:ACIU)’s traded shares stood at 1.88 million during the last session, with the company’s beta value hitting 0.56. At the close of trading, the stock’s price was $1.79, to imply an increase of 2.87% or $0.05 in intraday trading. The ACIU share’s 52-week high remains $5.40, putting it -201.68% down since that … Boom Or Bust: What Does The Future Hold For AC Immune SA (NASDAQ: ACIU) Stock? Read More »
AC Immune SA (NASDAQ:ACIU) Has Made The -3.09% Recovery, Could Gain Another -178.35% Ahead 2022/12/17 13:30:00 Marketing Sentinel
In last trading session, AC Immune SA (NASDAQ:ACIU) saw 0.61 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price level of $1.94 trading at -$0.1 or -4.90% at ring of the bell on the day assigns it a market valuation of $161.41M. That closing price of ACIU’s stock is … AC Immune SA (NASDAQ:ACIU) Has Made The -3.09% Recovery, Could Gain Another -178.35% Ahead Read More »
AC Immune Could Reload On Upcoming Readout 2022/12/06 12:42:34 Seeking Alpha
AC Immune has a lot of cash. Their lead vaccine was selected by a Big Pharma partner for later-stage development. See our analysis of ACIU stock here.
A Full Position In AC Immune To My Tax Loss Selling Basket (ACIU) 2022/12/27 18:02:46 Seeking Alpha
AC Immune recently fell due to what looks like indiscriminate tax loss selling. It now trades at near cash on hand. Read why I have a full position in ACIU.
Boom Or Bust: What Does The Future Hold For AC Immune SA (NASDAQ: ACIU) Stock? 2022/12/22 16:00:00 Marketing Sentinel
AC Immune SA (NASDAQ:ACIU)’s traded shares stood at 1.88 million during the last session, with the company’s beta value hitting 0.56. At the close of trading, the stock’s price was $1.79, to imply an increase of 2.87% or $0.05 in intraday trading. The ACIU share’s 52-week high remains $5.40, putting it -201.68% down since that … Boom Or Bust: What Does The Future Hold For AC Immune SA (NASDAQ: ACIU) Stock? Read More »
AC Immune SA (NASDAQ:ACIU) Has Made The -3.09% Recovery, Could Gain Another -178.35% Ahead 2022/12/17 13:30:00 Marketing Sentinel
In last trading session, AC Immune SA (NASDAQ:ACIU) saw 0.61 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price level of $1.94 trading at -$0.1 or -4.90% at ring of the bell on the day assigns it a market valuation of $161.41M. That closing price of ACIU’s stock is … AC Immune SA (NASDAQ:ACIU) Has Made The -3.09% Recovery, Could Gain Another -178.35% Ahead Read More »
AC Immune Could Reload On Upcoming Readout 2022/12/06 12:42:34 Seeking Alpha
AC Immune has a lot of cash. Their lead vaccine was selected by a Big Pharma partner for later-stage development. See our analysis of ACIU stock here.
AC Immune SA: AC Immune''s Alzheimer''s Disease Vaccine-candidate ACI-35.030 Selected for Further Development 2022/11/30 12:05:00 Finanz Nachrichten
AC Immune''s Alzheimer''s Disease Vaccine-candidate ACI-35.030 Selected for Further Development Data presented at CTAD 2022 confirm excellent clinical performance of ACI-35.030 vaccine candidateBased…